Hypertension aggravated and Dermatitis psoriasiform

Summary:

Dermatitis psoriasiform is found among people with Hypertension aggravated, especially for people who are male, 60+ old.

The study analyzes which people have Dermatitis psoriasiform with Hypertension aggravated. It is created by eHealthMe based on reports of 115 people who have Hypertension aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

115 people who have Hypertension Aggravated and Dermatitis Psoriasiform are studied.

What is Hypertension aggravated?

Hypertension aggravated (high blood pressure-aggravated) is found to be associated with 1,938 drugs and 719 conditions by eHealthMe.

What is Dermatitis psoriasiform?

Dermatitis psoriasiform (large white or silver flakes on the skin) is found to be associated with 486 drugs and 265 conditions by eHealthMe.

Number of Dermatitis psoriasiform in Hypertension aggravated reports submitted per year:

Would you have Dermatitis psoriasiform when you have Hypertension aggravated?

Gender of people who have Hypertension aggravated and experienced Dermatitis psoriasiform *:

Click here to view

Age of people who have Hypertension aggravated and experienced Dermatitis psoriasiform *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Dermatitis psoriasiform?

Check whether Dermatitis psoriasiform is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Hypertension aggravated (4,131 reports)
Dermatitis psoriasiform (1,812 reports)

COVID vaccines that are related to Dermatitis psoriasiform:

Common drugs associated with Dermatitis psoriasiform:

Humira: 329 reports
Methotrexate: 199 reports
Remicade: 133 reports
Enbrel: 132 reports

All the drugs that are associated with Dermatitis psoriasiform:

Dermatitis psoriasiform (486 drugs)

Common conditions associated with Dermatitis psoriasiform:

Rheumatoid arthritis: 261 reports
Crohn's disease: 241 reports
Psoriasis: 134 reports
High blood pressure: 115 reports

All the conditions that are associated with Dermatitis psoriasiform:

Dermatitis psoriasiform (265 conditions)

How the study uses the data?

The study is based on Dermatitis psoriasiform and Hypertension aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.